VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

Encompass Health Executive Compensation (FY25)

EHC · Birmingham, AL · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Mark Tarr
Latest say-on-pay support
=
May 7, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The Encompass Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Encompass Health brief$500Get the executive brief
Velarion Intel, one year, every company
348 figures on this page: 339 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Mark Tarr: $9,301,929 → $10,297,258 (10.7% higher)
Say-on-pay support: 97.6% → 96.5% (1.1 points lower)
CEO pay ratio: 204:1 → 203:1 (0.5% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Encompass Health's chief executive and what were they paid?
Mark Tarr was paid $10,297,258 in total compensation as President and Chief Executive Officer for fiscal 2025. Tarr's total was 10.7% higher than the $9,301,929 reported for fiscal 2024.
What was Encompass Health's say-on-pay result?
The say-on-pay proposal drew 96.5% of votes cast for or against in favor at the meeting held May 7, 2026 for fiscal 2025.
Which companies are in Encompass Health's peer group?
The disclosed peer group names Acadia Healthcare, Agilon health, Alignment Healthcare, Amedisys and AMN Healthcare, among others.
What is Encompass Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 203:1, against median employee compensation of $50,647.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark Tarr
President and Chief Executive Officer President and Chief Executive Officer
◇—◇◇◇—◇◇
Douglas Coltharp
Executive Vice President and Chief Financial Officer Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Barbara Jacobsmeyer
Chief Executive Officer, Home Health and Hospice
◇—◇◇——◇◇
Patrick Darby
Executive Vice President General Counsel and Secretary Executive Vice President General Counsel and Secretary
◇—◇◇◇—◇◇
Elissa Charbonneau
Chief Medical Officer
◇—◇—◇—◇◇
Andrew Price
Chief Accounting Officer
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark Tarr
President and Chief Executive Officer
◇—◇◇◇—◇◇
Douglas Coltharp
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Patrick Darby
Executive Vice President, General Counsel and Secretary
◇—◇◇◇—◇◇
Elissa Charbonneau
Chief Medical Officer
◇—◇—◇—◇◇
Andrew Price
Chief Accounting Officer
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark Tarr
President and Chief Executive Officer President and Chief Executive Officer
◇—◇◇◇—◇◇
Douglas Coltharp
Executive Vice President and Chief Financial Officer Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Patrick Darby
Executive Vice President General Counsel and Secretary Executive Vice President General Counsel and Secretary
◇—◇◇◇—◇◇
Elissa Charbonneau
J. Charbonneau Chief Medical Officer Chief Medical Officer
◇—◇—◇—◇◇
Andrew Price
Chief Accounting Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark Tarr
President and Chief Executive Officer
◇—◇◇◇—◇◇
Douglas Coltharp
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Patrick Tuer
Executive Vice President and Chief Operating Officer
◇—◇—◇—◇◇
Patrick Darby
Executive Vice President, General Counsel and Secretary
◇—◇◇◇—◇◇
Elissa Charbonneau
Chief Medical Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Douglas E. ColtharpPSU◇◇◇—◇—◇
Douglas E. ColtharpOPTION◇——◇—◇◇
Douglas E. ColtharpRSU◇——◇——◇
Elissa J. CharbonneauPSU◇◇◇—◇—◇
Elissa J. CharbonneauRSU◇——◇——◇
Mark J. TarrPSU◇◇◇—◇—◇
Mark J. TarrOPTION◇——◇—◇◇
Mark J. TarrRSU◇——◇——◇
Patrick DarbyPSU◇◇◇—◇—◇
Patrick DarbyOPTION◇——◇—◇◇
Patrick DarbyRSU◇——◇——◇
Patrick W. TuerPSU◇◇◇—◇—◇
Patrick W. TuerRSU◇——◇——◇
Patrick W. TuerRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Mark TarrPSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇3/4/2035
Option◇—◇3/1/2034
Option◇—◇3/1/2033
RSU◇◇——
RSU◇◇——
RSU◇◇——
Douglas ColtharpPSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇3/4/2035
Option◇—◇3/1/2034
Option◇—◇3/1/2033
RSU◇◇——
RSU◇◇——
RSU◇◇——
Patrick DarbyPSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇3/4/2035
Option◇—◇3/1/2034
Option◇—◇3/1/2033
RSU◇◇——
RSU◇◇——
RSU◇◇——
Patrick TuerPSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Elissa CharbonneauPSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Douglas Coltharp
Executive Vice President and Chief Financial Officer · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance cash amount◇
Elissa Charbonneau
Chief Medical Officer · Terms as described in the company’s compensation discussion
Severance cash amount◇
Clawback◇
Mark Tarr
President and Chief Executive Officer · Terms as described in the company’s compensation discussion
Severance cash amount◇
Clawback◇
Patrick Darby
Executive Vice President, General Counsel and Secretary · Terms as described in the company’s compensation discussion
Severance cash amount◇
Patrick Tuer
Executive Vice President and Chief Operating Officer · Severance agreement
Severance cash amount◇
Excise tax treatment◇
Clawback◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Greg D. Carmichael
Board chair
◇◇———◇◇
Leslye G. Katz
◇◇———◇◇
Christopher R. Reidy
◇◇———◇◇
Nancy M. Schlichting
◇◇———◇◇
Joan E. Herman
◇◇———◇◇
Kevin J. O'Connor
◇◇———◇◇
Terrance Williams
◇◇———◇◇
Edward M. Christie III
◇◇———◇◇
Patricia A. Maryland
◇◇———◇◇
Cain A. Hayes and Mark J. Tarr served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Acadia Healthcare ACHC
  • Agilon health AGL
  • Alignment Healthcare ALHC
  • Amedisys AMED
  • AMN Healthcare AMN
  • BrightSpring Health Services BTSG
  • Brookdale Senior Living BKD
  • Chemed CHE
  • Community Health Systems CYH
  • DaVita DVA
  • Ensign Group ENSG
  • Labcorp Holdings LH
  • ModivCare MODV
  • Option Care Health OPCH
  • PACS Group PACS
  • Quest Diagnostics DGX
  • R1 RCM RCM
  • Select Medical Holdings SEM
  • Surgery Partners SGRY
  • Universal Health Services UHS

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 7, 2026=◇◇◇
2024May 1, 2025=◇◇◇
2023May 2, 2024=◇◇◇
2022May 4, 2023=◇◇◇
2021May 5, 2022=◇◇◇
2020May 6, 2021=◇◇◇
2019May 6, 2020=◇◇◇
2018May 3, 2019=◇◇◇
2017May 3, 2018=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Mark Tarr (President and Chief Executive Officer), FY2025 total compensation $10,297,258 (base salary $1,100,000) [exec_comp, SEC accession 0000785161-26-000105, filed 2026-04-07]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Encompass Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Encompass Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Encompass Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Encompass Health's disclosed peer group is defensible, who names Encompass Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
348 figures on this page: 339 cited to the filing that reported them, 9 calculated from figures it prints.
339 cited to the filing
9 calculated from the filing

Documents cited

  1. 0000785161-26-000151
  2. 0000785161-26-000105
    CEO Pay Ratio · Compensation of Directors · Grants of Plan-Based Awards During 2025 · Outstanding Equity Awards at December 31, 2025 · and 1 more section
  3. 0000785161-25-000025
  4. 0000785161-25-000013
    Compensation Discussion and Analysis · Summary Compensation Table
  5. 0000785161-24-000031
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000785161-24-000020
    Compensation of Directors · Summary Compensation Table
  7. 0000785161-23-000034
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000785161-23-000024
    Summary Compensation Table
  9. 0000785161-22-000024
  10. 0000785161-21-000027
  11. 0000785161-20-000036
  12. 0000785161-19-000027
  13. 0000785161-18-000032
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Encompass Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/EHC (accessed 2026).
Short form: data: Velarion

The Encompass Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Encompass Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Peers Encompass Health discloses

The companies named in EHC's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}